Predictions
Bastide Le Confort
Start price
Target price
Perf. (%)
€17.88
27.04.24
27.04.24
-
27.04.25
27.04.25
11.30%
11.05.24
11.05.24
Could be worthwhile Investment >10% per year
Biogen Inc.
Start price
Target price
Perf. (%)
€194.35
27.04.24
27.04.24
€200.00
27.04.25
27.04.25
5.58%
12.05.24
12.05.24
Good rating
Standard Investments for future growth
Innovative
Differentiated customer and product portfolio
Biogen Inc.
Start price
Target price
Perf. (%)
€194.35
27.04.24
27.04.24
€200.00
27.04.25
27.04.25
5.58%
12.05.24
12.05.24
Good rating
Standard Investments for future growth
Innovative
Differentiated customer and product portfolio
Biogen Inc.
Start price
Target price
Perf. (%)
€194.35
27.04.24
27.04.24
€200.00
27.04.25
27.04.25
5.58%
12.05.24
12.05.24
Good rating
Standard Investments for future growth
Innovative
Differentiated customer and product portfolio
Cardiff Oncology Inc.
Start price
Target price
Perf. (%)
€3.73
25.04.24
25.04.24
-
25.04.25
25.04.25
0.80%
27.04.24
27.04.24
Risky Investment
Esperion Therapeutis.Inc.
Start price
Target price
Perf. (%)
€1.85
25.04.24
25.04.24
-
25.04.25
25.04.25
-1.11%
27.04.24
27.04.24
Fate Therapeutics Inc.
Start price
Target price
Perf. (%)
€3.60
25.04.24
25.04.24
-
25.04.25
25.04.25
-2.00%
27.04.24
27.04.24
Could be worthwhile Investment >10% per year
Riot Blockchain Inc.
Start price
Target price
Perf. (%)
€10.85
23.04.24
23.04.24
€15.00
23.04.25
23.04.25
-2.67%
27.04.24
27.04.24
Abeona Therapeutics Inc.
Start price
Target price
Perf. (%)
€3.52
23.04.24
23.04.24
-
23.04.25
23.04.25
-11.36%
28.04.24
28.04.24
Abeona Therapeutics Inc.
Start price
Target price
Perf. (%)
€3.68
23.04.24
23.04.24
-
23.04.25
23.04.25
-15.22%
27.04.24
27.04.24
Fibrogen Inc.
Start price
Target price
Perf. (%)
€1.07
19.04.24
19.04.24
-
19.04.25
19.04.25
-10.90%
28.04.24
28.04.24
Could be very worthwhile Investment >20% year
Fate Therapeutics Inc.
Start price
Target price
Perf. (%)
€4.50
19.04.24
19.04.24
-
19.04.25
19.04.25
-12.02%
10.05.24
10.05.24
Could be very worthwhile Investment >20% year
MacroGenics Inc.
Start price
Target price
Perf. (%)
€14.60
19.04.24
19.04.24
€20.00
16.03.25
16.03.25
-78.19%
13.05.24
13.05.24
Pacific Biosciences of California Inc.
Start price
Target price
Perf. (%)
€1.31
16.04.24
16.04.24
-
16.04.25
16.04.25
6.59%
27.04.24
27.04.24
Pacific Biosciences of California Inc.
Start price
Target price
Perf. (%)
€1.63
16.04.24
16.04.24
-
16.04.25
16.04.25
-14.11%
28.04.24
28.04.24
Viking Therapeutics Inc
Start price
Target price
Perf. (%)
€62.08
16.04.24
16.04.24
-
22.03.25
22.03.25
14.66%
30.04.24
30.04.24
Adaptimmune Therapeutics PLC ADR
Start price
Target price
Perf. (%)
€1.00
15.04.24
15.04.24
-
15.04.25
15.04.25
11.00%
30.04.24
30.04.24
Enlivex Therapeutics Ltd.
Start price
Target price
Perf. (%)
€1.24
15.04.24
15.04.24
-
12.04.25
12.04.25
12.90%
18.04.24
18.04.24
aTyr Pharma Inc
Start price
Target price
Perf. (%)
€1.66
14.04.24
14.04.24
-
14.04.25
14.04.25
-13.86%
28.04.24
28.04.24
Could be worthwhile Investment >10% per year
Enlivex Therapeutics Ltd.
Start price
Target price
Perf. (%)
€1.51
14.04.24
14.04.24
-
14.04.25
14.04.25
-0.66%
28.04.24
28.04.24
Adaptimmune Therapeutics PLC ADR
Start price
Target price
Perf. (%)
€1.07
13.04.24
13.04.24
€1.00
13.04.25
13.04.25
-2.80%
27.04.24
27.04.24
Probably not worthwhile Investment
Lower EBIT Margin than peer group
Bad rating
ROE lower than 10% per year
Inotiv Inc.
Start price
Target price
Perf. (%)
€5.50
13.04.24
13.04.24
€4.00
13.04.25
13.04.25
-32.36%
27.04.24
27.04.24
Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Little Investments for future growth
Enlivex Therapeutics Ltd.
Start price
Target price
Perf. (%)
€1.51
13.04.24
13.04.24
€2.00
13.04.25
13.04.25
-0.66%
27.04.24
27.04.24
negative Cash Flow expected
Few uniques
Growths slower than the competition
Below average Marketposition
Enlivex Therapeutics Ltd.
Start price
Target price
Perf. (%)
€1.48
12.04.24
12.04.24
-
12.04.25
12.04.25
-16.22%
15.04.24
15.04.24